Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort

Management for HCV has undergone a notable change using direct-acting antiviral drugs (DAAs), which are safe and effective even in elderly. Here, we define impact of comorbidities, concomitant medication and drug–drug interactions in elder patients with HCV related disease before starting DAAs regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Licata, Anna, Minissale, Maria Giovanna, Giannitrapani, Lydia, Montalto, Filippo A., Lombardo, Clelia, Mirarchi, Luigi, Amodeo, Simona, Soresi, Maurizio, Montalto, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841322/
https://www.ncbi.nlm.nih.gov/pubmed/33909256
http://dx.doi.org/10.1007/s11739-021-02741-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841322/
https://www.ncbi.nlm.nih.gov/pubmed/33909256
http://dx.doi.org/10.1007/s11739-021-02741-9

Ejemplares similares